Very few coincident tumor suppressor alterations have been investigated in the context of oncogenic BRAF-driven autochthonous lung tumors, and the extent to which tumor suppressor effects differ in EGFR-driven tumors remains poorly understood (Supplementary Fig. 1)36,41–44. The gene discussed is BRAF; the disease is neoplasm.